Literature DB >> 18471976

The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.

Shashwati Basak1, Suzanne B R Jacobs, Adam J Krieg, Navneeta Pathak, Qi Zeng, Philipp Kaldis, Amato J Giaccia, Laura D Attardi.   

Abstract

The p53 tumor suppressor restricts tumorigenesis through the transcriptional activation of target genes involved in cell-cycle arrest and apoptosis. Here, we identify Prl-3 (phosphatase of regenerating liver-3) as a p53-inducible gene. Whereas previous studies implicated Prl-3 in metastasis because of its overexpression in metastatic human colorectal cancer and its ability to promote invasiveness and motility, we demonstrate here that Prl-3 is an important cell-cycle regulator. Consistent with a role in DNA damage-induced cell-cycle arrest, Prl-3 overexpression induces G(1) arrest downstream of p53 by triggering a PI3K-Akt-activated negative feedback loop. Surprisingly, attenuation of Prl-3 expression also elicits an arrest response, suggesting that basal level Prl-3 expression is pivotal for normal cell-cycle progression. Our findings highlight key dose-dependent functions of Prl-3 in both positive and negative regulation of cell-cycle progression and provide insight into Prl-3's role in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471976      PMCID: PMC3951836          DOI: 10.1016/j.molcel.2008.04.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  39 in total

Review 1.  Centrosome duplication. a centriolar pas de deux.

Authors:  T Stearns
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

2.  Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.

Authors:  W F Matter; T Estridge; C Zhang; R Belagaje; L Stancato; J Dixon; B Johnson; L Bloem; T Pickard; M Donaghue; S Acton; R Jeyaseelan; V Kadambi; C J Vlahos
Journal:  Biochem Biophys Res Commun       Date:  2001-05-25       Impact factor: 3.575

Review 3.  Cell cycle and death control: long live Forkheads.

Authors:  Boudewijn M T Burgering; Geert J P L Kops
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

Review 4.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

5.  Cell cycle-regulated phosphorylation of p220(NPAT) by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription.

Authors:  T Ma; B A Van Tine; Y Wei; M D Garrett; D Nelson; P D Adams; J Wang; J Qin; L T Chow; J W Harper
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

6.  p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.

Authors:  C Chao; S Saito; J Kang; C W Anderson; E Appella; Y Xu
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

7.  A phosphatase associated with metastasis of colorectal cancer.

Authors:  S Saha; A Bardelli; P Buckhaults; V E Velculescu; C Rago; B St Croix; K E Romans; M A Choti; C Lengauer; K W Kinzler; B Vogelstein
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

8.  Cdk2 knockout mice are viable.

Authors:  Cyril Berthet; Eiman Aleem; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Curr Biol       Date:  2003-10-14       Impact factor: 10.834

9.  The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor.

Authors:  Or Gozani; Philip Karuman; David R Jones; Dmitri Ivanov; James Cha; Alexey A Lugovskoy; Cheryl L Baird; Hong Zhu; Seth J Field; Stephen L Lessnick; Jennifer Villasenor; Bharat Mehrotra; Jian Chen; Vikram R Rao; Joan S Brugge; Colin G Ferguson; Bernard Payrastre; David G Myszka; Lewis C Cantley; Gerhard Wagner; Nullin Divecha; Glenn D Prestwich; Junying Yuan
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

10.  PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.

Authors:  Qi Zeng; Jing-Ming Dong; Ke Guo; Jie Li; Hui-Xian Tan; Vicki Koh; Catherine J Pallen; Edward Manser; Wanjin Hong
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

View more
  44 in total

1.  The Hippo pathway promotes cell survival in response to chemical stress.

Authors:  F Di Cara; T M Maile; B D Parsons; A Magico; S Basu; N Tapon; K King-Jones
Journal:  Cell Death Differ       Date:  2015-03-13       Impact factor: 15.828

2.  Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice.

Authors:  Julie M Cramer; Mark W Zimmerman; Tim Thompson; Gregg E Homanics; John S Lazo; Eric Lagasse
Journal:  Stem Cell Res       Date:  2014-05-27       Impact factor: 2.020

3.  Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.

Authors:  Hsin-Chih Yeh; Chun-Nung Huang; Ching-Chia Li; Lin-Li Chang; Hui-Hui Lin; Hung-Lung Ke; A-Mei Huang; Peir-In Liang; Chien-Feng Li; Wen-Jeng Wu
Journal:  World J Urol       Date:  2015-10-03       Impact factor: 4.226

4.  Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer.

Authors:  Ru-Tian Hao; Xiao-Hua Zhang; Yi-Fei Pan; Hai-Guang Liu; You-Qun Xiang; Li Wan; Xiu-Ling Wu
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

5.  Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.

Authors:  John S Lazo; Isabella K Blanco; Nikhil R Tasker; Ettore J Rastelli; James C Burnett; Sharon R Garrott; Duncan J Hart; Rebecca L McCloud; Ku-Lung Hsu; Peter Wipf; Elizabeth R Sharlow
Journal:  J Pharmacol Exp Ther       Date:  2019-10-10       Impact factor: 4.030

6.  A role of autophagy in PTP4A3-driven cancer progression.

Authors:  Yu-Han Huang; Abdul Qader O Al-Aidaroos; Hiu-Fung Yuen; Shu-Dong Zhang; Han-Ming Shen; Ewelina Rozycka; Cian M McCrudden; Vinay Tergaonkar; Abhishek Gupta; You Bin Lin; Jean Paul Thiery; James T Murray; Qi Zeng
Journal:  Autophagy       Date:  2014-08-01       Impact factor: 16.016

Review 7.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

8.  Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.

Authors:  Ahmet Bilici; Bala Basak Oven Ustaalioglu; Dilek Yavuzer; Mesut Seker; Alpaslan Mayadagli; Mahmut Gumus
Journal:  Dig Dis Sci       Date:  2012-02-14       Impact factor: 3.199

9.  Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).

Authors:  Tasuku Ishii; Yosuke Funato; Hiroaki Miki
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.